Illumina (ILMN) Non Operating Interest Expenses (2009 - 2026)
Illumina's (ILMN) quarterly Non Operating Interest Expenses came in at $24.0 million in Q2 2026, down 4.0% on a YoY basis from $25.0 million in Q2 2025, and little changed quarter-over-quarter from $24.0 million in Q1 2026.
Analysis
Illumina (ILMN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Illumina (ILMN) has reported Non Operating Interest Expenses for 18 consecutive years, with $24.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 4.0% year-over-year to $24.0 million; the trailing twelve-month figure through Jun 2026 stood at $99.0 million (down 10.81% YoY), and the FY2025 full-year result was $101.0 million, up 1.0% from the prior year.
- Non Operating Interest Expenses held at $24.0 million in Q2 2026 per ILMN's latest filing, from $24.0 million in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $36.0 million in Q3 2024 and bottomed at -$22.0 million in Q1 2023.
- Historically, Non Operating Interest Expenses has averaged $17.8 million across 5 years, with a median of $20.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses tumbled 68.42% in 2022, then jumped 233.33% in 2023.
- Over 5 years, Non Operating Interest Expenses stood at $6.0 million in 2022, then jumped by 200.0% to $18.0 million in 2023, then jumped by 38.89% to $25.0 million in 2024, then grew by 4.0% to $26.0 million in 2025, then declined by 7.69% to $24.0 million in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $24.0 million, $24.0 million, and $26.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 401.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 107.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 29.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 24.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 25.79 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 2.12 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 12.10 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 5.66 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 17.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 24.00 Mn |
| Mar 29, 2026 | 24.00 Mn |
| Dec 28, 2025 | 26.00 Mn |
| Sep 28, 2025 | 25.00 Mn |
| Jun 29, 2025 | 25.00 Mn |
| Mar 30, 2025 | 25.00 Mn |
| Dec 29, 2024 | 25.00 Mn |
| Sep 29, 2024 | 36.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 18.00 Mn |
| Dec 31, 2023 | 18.00 Mn |
| Oct 1, 2023 | 19.00 Mn |
| Jul 2, 2023 | 19.00 Mn |
| Apr 2, 2023 | 20.00 Mn |
| Jan 1, 2023 | -22.00 Mn |
| Oct 2, 2022 | 6.00 Mn |
| Jul 3, 2022 | 6.00 Mn |
| Apr 3, 2022 | 6.00 Mn |
| Oct 3, 2021 | 14.00 Mn |
| Jul 4, 2021 | 16.00 Mn |